What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His primary scientific interests are in Internal medicine, Surgery, Rheumatoid arthritis, Immunology and Rheumatology.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Physical therapy.
His Surgery research incorporates elements of Giant cell arteritis, Cohort and Hazard ratio.
His research integrates issues of Risk factor, Disease and Arthritis in his study of Rheumatoid arthritis.
His work deals with themes such as Guideline, Severity of illness and Rheumatoid vasculitis, which intersect with Rheumatology.
In his study, which falls under the umbrella issue of Randomized controlled trial, Adalimumab and Infliximab is strongly linked to Clinical trial.
His most cited work include:
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides (2901 citations)
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies: Systematic Review and Meta-analysis of Rare Harmful Effects in Randomized Controlled Trials (2069 citations)
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis (1547 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Rheumatoid arthritis, Cohort, Surgery and Incidence.
As a part of the same scientific family, Eric L. Matteson mostly works in the field of Internal medicine, focusing on Physical therapy and, on occasion, Intensive care medicine.
His biological study spans a wide range of topics, including Disease and Arthritis.
His Cohort study integrates concerns from other disciplines, such as Proportional hazards model, Cumulative incidence, Cohort study and Hazard ratio.
As part of the same scientific family, Eric L. Matteson usually focuses on Surgery, concentrating on Placebo and intersecting with Adverse effect.
Within one scientific family, Eric L. Matteson focuses on topics pertaining to Epidemiology under Incidence, and may sometimes address concerns connected to Sarcoidosis.
He most often published in these fields:
- Internal medicine (52.30%)
- Rheumatoid arthritis (33.22%)
- Cohort (20.23%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (52.30%)
- Rheumatoid arthritis (33.22%)
- Cohort (20.23%)
In recent papers he was focusing on the following fields of study:
Eric L. Matteson spends much of his time researching Internal medicine, Rheumatoid arthritis, Cohort, Incidence and In patient.
His Internal medicine and Rheumatology, Giant cell arteritis, Hazard ratio, Adverse effect and Retrospective cohort study investigations all form part of his Internal medicine research activities.
His studies deal with areas such as Rheumatism and Family medicine as well as Rheumatology.
His Rheumatoid arthritis research integrates issues from Interstitial lung disease, Disease and Arthritis.
His Cohort research includes elements of Discontinuation, Heart failure, Population based study, Confidence interval and Mean age.
He has included themes like Epidemiology, Pediatrics, Rochester Epidemiology Project and Medical record in his Incidence study.
Between 2017 and 2021, his most popular works were:
- Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis (98 citations)
- Large-vessel giant cell arteritis: diagnosis, monitoring and management (58 citations)
- The Epidemiology of Antiphospholipid Syndrome: A Population-Based Study. (49 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Internal medicine, Rheumatoid arthritis, Giant cell arteritis, Adverse effect and Disease are his primary areas of study.
His Rheumatology, Cohort, Incidence, Relative risk and Randomized controlled trial investigations are all subjects of Internal medicine research.
Rheumatoid arthritis is a primary field of his research addressed under Immunology.
He focuses mostly in the field of Giant cell arteritis, narrowing it down to topics relating to Radiology and, in certain cases, Arteritis and MEDLINE.
Eric L. Matteson combines subjects such as Cushingoid, Osteoporosis, Adrenal insufficiency and Glucocorticoid with his study of Adverse effect.
Eric L. Matteson has researched Disease in several fields, including Sarcoidosis, Dermatology and Cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
